US-listed company Basel Medical Group has suspended its Bitcoin acquisition strategy
According to ChainCatcher, as reported by Cointelegraph, US-listed company Basel Medical Group Ltd announced today that it has suspended its Bitcoin acquisition strategy, citing ongoing regulatory uncertainty surrounding digital assets in the United States.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ethereum's net supply increased by 18,469 in the past 7 days
Swiss crypto bank Amina Bank completes DLT settlement test via Google Cloud
Data: Machi increases Ethereum long positions to $28.6 millions, with an entry price of $2,981.59
Nasdaq: Approval of its tokenized stock program by the SEC is now a top priority
Trending news
MoreCrypto prices
More
